GV 2017, L.P., Insider at Verve Therapeutics, Inc. (VERV), sold 295,078 shares at $34.78 ($7.3M) on 2022-11-02, disclosed to the SEC on 2022-11-04.
Open-market sale of $7.3M VERV by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 28,651 | $0 | 0.0% |
| 2 | $34.78 | 9,349 | $325K | 4.4% |
| 3 | $34.78 | 9,349 | $325K | 4.4% |
| 4 | $34.78 | 9,350 | $325K | 4.4% |
| 5 | $36.28 | 10,372 | $376K | 5.1% |
| 6 | $36.28 | 10,372 |
| $376K |
| 5.1% |
| 7 | $36.78 | 8,930 | $328K | 4.5% |
| 8 | $36.78 | 8,930 | $328K | 4.5% |
| 9 | $0.00 | 49,569 | $0 | 0.0% |
| 10 | $32.32 | 22,279 | $720K | 9.8% |
| 11 | $32.32 | 22,279 | $720K | 9.8% |
| 12 | $33.14 | 25,535 | $846K | 11.5% |
| 13 | $33.14 | 25,534 | $846K | 11.5% |
| 14 | $33.14 | 25,535 | $846K | 11.5% |
| 15 | $33.14 | 25,534 | $846K | 11.5% |
| 16 | $33.84 | 1,755 | $59K | 0.8% |
| 17 | $33.84 | 1,755 | $59K | 0.8% |
| Total | $24.84 avg | 295,078 | $7.3M | 100% |